Recruiting Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) NCT07608432 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DMD, Duchenne Muscular Dystrophy (DMD), +21 more Locations Rare Disease Research, LLC — Hillsborough, North Carolina, United States View Trial Details
Recruiting Vasodilator and Exercise Study for DMD (VASO-REx) NCT06290713 Conditions Aneurysm, Bacterial Infections, Bacterial Infections and Mycoses, +32 more Locations University of Florida Clinical and Translational Research Building — Gainesville, Florida, United States View Trial Details
Active, Not Recruiting Defining Endpoints in Becker Muscular Dystrophy NCT05257473 Conditions Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +10 more Locations University of California, Irvine — Orange, California, United States University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States University of Iowa — Iowa City, Iowa, United States University of Kansas Medical Center — Kansas City, Kansas, United States View more locations Show fewer locations Loading locations... View Trial Details
